Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 39.78
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Gujarat Terce Laboratories Ltd. engages in the manufacture and sale of pharmaceutical products. Its product portfolio encompasses therapeutics relating to anti fungal, anti malarial, antibiotic, ayurvedic, cardiovascular therapy, gastrointestinal therapy, gynecological, miscellaneous, nutraceutical, pain therapy, and respiratory system. The company was founded by Mr. N.P. Prajapati on March 28, 1985 and is headquartered in in...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is undervalued on EV/EBITDA.
Data is available to registered users only
Buy
Sell